TY - JOUR
T1 - Overexpression of lymphotoxin in T cells induces fulminant thymic involution
AU - Heikenwalder, Mathias
AU - Prinz, Marco
AU - Zeller, Nicolas
AU - Lang, Karl S.
AU - Junt, Tobias
AU - Rossi, Simona
AU - Tumanov, Alexei
AU - Schmidt, Hauke
AU - Priller, Josef
AU - Flatz, Lukas
AU - Rülicke, Thomas
AU - Macpherson, Andrew J.
AU - Holländer, Georg A.
AU - Nedospasov, Sergei A.
AU - Aguzzi, Adriano
N1 - Funding Information:
Supported by grants from the Bundesamt für Bildung und Wissenschaft, the Swiss National Foundation (SNF), and the National Center of Competence in Research on neural plasticity (to A.A.), an EMBO fellowship (to J.P.), the foundation for Research at the Medical Faculty, the University of Zurich, the Verein zur Förderung des akademischen Nachwuchses (FAN), the Schweizer-MS foundation, the Bonizzi-Theler foundation and the Prof. Dr. Max-Cloëtta and Bonizzi-Theler foundation (to M.H.). S.A.N. is an International Research Scholar of the Howard Hughes Medical Institute. G.A.H. was supported by a grant ( FP6 ) of the European Union, the SNF (grant 3100-68310.02 ), and the NIH (grant ROI-A1057477–01 ).
PY - 2008/6
Y1 - 2008/6
N2 - Activated lymphocytes and lymphoid-tissue inducer cells express lymphotoxins (LTs), which are essential for the organogenesis and maintenance of lymphoreticular microenvironments. Here we describe that T-cell-restricted overexpression of LT induces fulminant thymic involution. This phenotype was prevented by ablation of the LT receptors tumor necrosis factor receptor (TNFR) 1 or LT beta receptor (LTβR), representing two non-redundant pathways. Multiple lines of transgenic Ltαβ and Ltα mice show such a phenotype, which was not observed on overexpression of LTβ alone. Reciprocal bone marrow transfers between LT-overexpressing and receptor-ablated mice show that involution was not due to a T cell-autonomous defect but was triggered by TNFR1 and LTβR signaling to radioresistant stromal cells. Thymic involution was partially prevented by the removal of one allele of LTβR but not of TNFR1, establishing a hierarchy in these signaling events. Infection with the lymphocytic choriomeningitis virus triggered a similar thymic pathology in wt, but not in Tnfr1-/- mice. These mice displayed elevated TNFα in both thymus and plasma, as well as increased LTs on both CD8+ and CD4-CD8- thymocytes. These findings suggest that enhanced T cell-derived LT expression helps to control the physiological size of the thymic stroma and accelerates its involution via TNFR1/LTβR signaling in pathological conditions and possibly also in normal aging.
AB - Activated lymphocytes and lymphoid-tissue inducer cells express lymphotoxins (LTs), which are essential for the organogenesis and maintenance of lymphoreticular microenvironments. Here we describe that T-cell-restricted overexpression of LT induces fulminant thymic involution. This phenotype was prevented by ablation of the LT receptors tumor necrosis factor receptor (TNFR) 1 or LT beta receptor (LTβR), representing two non-redundant pathways. Multiple lines of transgenic Ltαβ and Ltα mice show such a phenotype, which was not observed on overexpression of LTβ alone. Reciprocal bone marrow transfers between LT-overexpressing and receptor-ablated mice show that involution was not due to a T cell-autonomous defect but was triggered by TNFR1 and LTβR signaling to radioresistant stromal cells. Thymic involution was partially prevented by the removal of one allele of LTβR but not of TNFR1, establishing a hierarchy in these signaling events. Infection with the lymphocytic choriomeningitis virus triggered a similar thymic pathology in wt, but not in Tnfr1-/- mice. These mice displayed elevated TNFα in both thymus and plasma, as well as increased LTs on both CD8+ and CD4-CD8- thymocytes. These findings suggest that enhanced T cell-derived LT expression helps to control the physiological size of the thymic stroma and accelerates its involution via TNFR1/LTβR signaling in pathological conditions and possibly also in normal aging.
UR - http://www.scopus.com/inward/record.url?scp=44849139209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44849139209&partnerID=8YFLogxK
U2 - 10.2353/ajpath.2008.070572
DO - 10.2353/ajpath.2008.070572
M3 - Article
C2 - 18483211
AN - SCOPUS:44849139209
SN - 0002-9440
VL - 172
SP - 1555
EP - 1570
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 6
ER -